Home/Filings/4/0000943819-25-000170
4//SEC Filing

Farrell Michael J. 4

Accession 0000943819-25-000170

CIK 0000943819other

Filed

Nov 23, 7:00 PM ET

Accepted

Nov 24, 10:42 AM ET

Size

7.1 KB

Accession

0000943819-25-000170

Insider Transaction Report

Form 4
Period: 2025-11-20
Farrell Michael J.
DirectorChairman and CEO
Transactions
  • Tax Payment

    ResMed Common Stock

    2025-11-207,297466,223 total
  • Award

    ResMed Common Stock

    2025-11-20+13,551473,520 total
Holdings
  • ResMed Common Stock

    (indirect: By Trust)
    2,090
Footnotes (2)
  • [F1]Represents performance-based restricted stock units granted on November 16, 2022. The shares were earned on November 20, 2025, when the compensation and leadership development committee certified that the performance metrics were met.
  • [F2]Disposition to issuer for tax withholding on vesting of performance-based restricted stock units granted on November 16, 2022.

Issuer

RESMED INC

CIK 0000943819

Entity typeother

Related Parties

1
  • filerCIK 0001485164

Filing Metadata

Form type
4
Filed
Nov 23, 7:00 PM ET
Accepted
Nov 24, 10:42 AM ET
Size
7.1 KB